Director, Accounting in San Francisco, CA

Save

compensation:

$200K - $250K

specialty:

Accounting, Corporate Finance

experience:

11 - 15 years

Job Description

Directs the activities of general accounting functions. Develops, implements, and maintains systems, procedures and policies, including all general accounting functions. Ensures the accurate compilation, analysis and reporting of accounting data. Acts as a liaison between the company, government, CPA and other auditors in providing the required information and ensuring that proper information is maintained for historical purposes. Supports the preparation of federal, state and local reports and tax returns. Creates and interprets reports and records for management. Supports management in the preparation of management reporting, financial analysis and financial statements. May select, develop, and evaluate personnel to ensure the efficient operation of the function.

Participates with other senior managers to establish strategic plans and objectives. Makes final decisions on administrative or operational matters and ensures operations effective achievement of objectives. Works o

See More

Valid through: 2020-1-20

About Nektar Therapeutics

Nektar Therapeutics (Nektar) (NASDAQ: NKTR) is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the worlds first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough. Exubera was also recognized as the most innovative diabetes medicine of 2006 in Germany. The company is engaged in developing a propriety pipeline of drug candidates for several therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology. The companys research and development involve in small molecule and biologic drug candidates. Its drug candidate base consists of naloxegol (Movantik), a Phase III oral opioid antagonist, etirinotecan pegol, a topoisomerase inhibitor under Phase III clinical study as of 2012, NKTR 061, NKTR-181, NKTR-214, etc. In 2013, the company was assignment a patent which was developed by the company and other four co-inventors. The products of the company is served as a supplement to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability and other areas of drugs for the patients worldwide. As of March 2014, the company had an market capitalization of $1.7 billion with an enterprise value of $1.67 billion.
Total Jobs:
40
Average Pay:
$148,875
Total value of jobs:
$31,115,000
% Masters:
42%
Learn More About Nektar Therapeutics

More Jobs at Nektar Therapeutics

Similar Jobs

More Pharmaceuticals & Biotech Jobs

Find similar Director of Accounting jobs: